The Co-Development Imperative: Aligning the Pharma and Diagnostics Industries for Synchronized Product Launches
  The successful commercialization of a targeted oncology therapy is now highly dependent on the "co-development" strategy—the simultaneous, synergistic development and regulatory submission of a pharmaceutical drug and its corresponding Companion Diagnostic (CDx) test. This integrated approach, strongly encouraged by regulatory bodies like the FDA, is a departure from historical...
0 Comentários 0 Compartilhamentos 205 Visualizações 0 Anterior
Patrocinado